Field trials reveal the complexities of deploying and evaluating the impacts of yeast-baited ovitraps on Aedes mosquito densities in Trinidad, West Indies
- PMID: 35260697
- PMCID: PMC8904463
- DOI: 10.1038/s41598-022-07910-0
Field trials reveal the complexities of deploying and evaluating the impacts of yeast-baited ovitraps on Aedes mosquito densities in Trinidad, West Indies
Abstract
The use of lure-and-kill, large-volume ovitraps to control Aedes aegypti and Aedes albopictus populations has shown promise across multiple designs that target gravid females (adulticidal) or larvae post-oviposition (larvicidal). Here we report on a pilot trial to deploy 10 L yeast-baited ovitraps at select sites in Curepe, Trinidad, West Indies during July to December, 2019. Oviposition rates among ovitraps placed in three Treatment sites were compared to a limited number of traps placed in three Control areas (no Aedes management performed), and three Vector areas (subjected to standard Ministry of Health, Insect Vector Control efforts). Our goal was to gain baseline information on efforts to saturate the Treatment sites with ovitraps within 20-25 m of each other and compare oviposition rates at these sites with background oviposition rates in Control and Vector Areas. Although yeast-baited ovitraps were highly attractive to gravid Aedes females, a primary limitation encountered within the Treatment sites was the inability to gain access to residential compounds for trap placement, primarily due to residents being absent during the day. This severely limited our intent to saturate these areas with ovitraps, indicating that future studies must include plans to account for these inaccessible zones during trap placement.
© 2022. The Author(s).
Conflict of interest statement
MDS and DWS filed a patent application with the U. S. Patent Office. All other authors have no conflict of interest.
Figures







References
-
- Gratz NG. Critical review of the vector status of Aedes albopictus. Med. Vet. Entomol. 2004;18:215–227. - PubMed
-
- Wilder-Smith A, et al. Epidemic arboviral diseases: priorities for research and public health. Lancet Infect. Dis. 2017;17:e101–e106. - PubMed
-
- Felicetti T, Manfroni G, Cecchetti V, Cannalire R. Broad-spectrum flavivirus inhibitors: a medicinal chemistry point of view. Chem. Med. Chem. 2020;15:2391–2419. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources